Skip to main content

Table 1 Prevalence of Pfmdr1 haplotypes at codon N86Y, Y184F and D1246Y in Maputo, before and after the introduction of artemisinin-based combination therapy

From: Prevalence of pfmdr1 alleles associated with artemether-lumefantrine tolerance/resistance in Maputo before and after the implementation of artemisinin-based combination therapy

Codon Haplotype 2003-2005* 2010-2012*
86/184 (49;293) NF 10.2 24.3
  YF 8.2 0.3
  NY 12.2 59.4
  YY 69.4 16.0
86/1246 (77;286) ND 27.3 84.4
  NY 1.3 0.3
  YD 64.9 13.6
  YY 6.5 1.7
184/1246 (53;330) FY 0.0 0.0
  FD 20.8 23.3
  YY 7.5 2.4
  YD 71.7 74.3
86/184/1246 (45;282) NFD 11.1 24.8
  NFY 0.0 0.0
  NYY 2.2 0.4
  NYD 11.1 59.2
  YYY 4.4 1.8
  YFD 8.9 0.4
  YFY 0.0 0.0
  YYD 62.2 13.5
  1. *Sample collection period. Numbers in brackets represent number of samples collectedduring the correspondent periods 2003–2005;2010–2012.